Targeting SOD1 to Treat Familial ALS

Authors

  • Clinical Research News The Clinical Research News section generally contributed by the ROS Editorial Staff aims to report important original clinical research findings in a news format of maximally 500 words in length with no more than one illustration and no more than 10 references cited. The clinical research findings are related to ROS/antioxidants and are typically published in highly influential journals (usually with an impact factor of more than 10) within the past 6 months.

Downloads

Published

2020-12-01

How to Cite

Clinical Research News. (2020). Targeting SOD1 to Treat Familial ALS. Reactive Oxygen Species, 10(29), 178–179. Retrieved from https://rosj.org/index.php/ros/article/view/279

Issue

Vol. 10 No. 29 (2020)

Section

Clinical Research News

License

Submission of an original manuscript to the Journal will be taken to mean that it represents original work not previously published; that it is not being considered elsewhere for publication; that the author(s) agrees to assign copyright to the Journal upon acceptance for publication in the Journal, and if accepted for publication, it will be published in the digital format (PDF) and/or in print and it will not be published elsewhere in the same form, for commercial purposes, in any language, without the consent of the Publisher.